- Home
- WTS vs GH Comparison
WTS vs GH Comparison
Compare WTS & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTS
- GH
- Stock Information
- Founded
- WTS 1874
- GH 2011
- Country
- WTS United States
- GH United States
- Employees
- WTS N/A
- GH N/A
- Industry
- WTS Metal Fabrications
- GH Medical Specialities
- Sector
- WTS Industrials
- GH Health Care
- Exchange
- WTS Nasdaq
- GH Nasdaq
- Market Cap
- WTS 7.1B
- GH 6.1B
- IPO Year
- WTS 1986
- GH 2018
- Fundamental
- Price
- WTS $214.83
- GH $42.87
- Analyst Decision
- WTS Hold
- GH Strong Buy
- Analyst Count
- WTS 5
- GH 18
- Target Price
- WTS $220.00
- GH $44.88
- AVG Volume (30 Days)
- WTS 211.5K
- GH 2.3M
- Earning Date
- WTS 02-10-2025
- GH 02-20-2025
- Dividend Yield
- WTS 0.80%
- GH N/A
- EPS Growth
- WTS 11.13
- GH N/A
- EPS
- WTS 8.69
- GH N/A
- Revenue
- WTS $2,252,200,000.00
- GH $739,016,000.00
- Revenue This Year
- WTS $1.15
- GH $33.18
- Revenue Next Year
- WTS $3.51
- GH $16.41
- P/E Ratio
- WTS $24.81
- GH N/A
- Revenue Growth
- WTS 9.53
- GH 31.04
- 52 Week Low
- WTS $175.37
- GH $15.81
- 52 Week High
- WTS $232.60
- GH $50.89
- Technical
- Relative Strength Index (RSI)
- WTS 53.50
- GH 45.70
- Support Level
- WTS $213.72
- GH $47.03
- Resistance Level
- WTS $220.46
- GH $49.90
- Average True Range (ATR)
- WTS 5.82
- GH 2.62
- MACD
- WTS 0.57
- GH -0.60
- Stochastic Oscillator
- WTS 47.35
- GH 13.32
About WTS Watts Water Technologies Inc.
Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, and heating systems; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. The company generates the majority of its revenue from markets in the Americas and in Europe, the Middle East, and Africa.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.